BIO CEO & Investor Conference
Date
  • Show All
Time
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO CEO & Investor Conference
Jump to Day
  • Show All
Sunday, February 5
6:00 PM - 8:00 PM (EST)
This event is at capacity.  If you are registered, you have received a confirmation email from…
Monday, February 6
9:00 AM - 11:45 AM (EST)
Company Presentations will take place in the Winter Garden, Palace and Music Box rooms on the 6th…
9:15 AM - 10:00 AM (EST)
Kathy Fernando is a Senior Vice President and Global Head of the Partner…
South Broadway Ballroom
10:00 AM - 10:45 AM (EST)
With the volatility of public markets in 2022, many companies have considered additional raises…
South Broadway Ballroom
11:00 AM - 11:45 AM (EST)
Immuno-oncology therapies have revolutionized the treatment of many cancers over the last decade,…
South Broadway Ballroom
12:15 PM - 1:00 PM (EST)
Lars Enstrom is a Managing Director on the Credit and Royalty team, focused on structured finance…
South Broadway Ballroom
1:00 PM - 1:45 PM (EST)
According to GBI-Healthcare data, Chinese biotechs entered into 46 out-licensing deals and 160 in…
South Broadway Ballroom
1:15 PM - 5:00 PM (EST)
Company Presentations will take place in the Winter Garden, Palace and Music Box rooms on the 6th…
2:00 PM - 2:45 PM (EST)
Atlas Venture reports in its 2022 Year in Review, there are "7000 drugs in clinical development…
South Broadway Ballroom
3:00 PM - 3:45 PM (EST)
With more than $500 billion flowing into ESG-focused funds over the past year, this fastest growing…
South Broadway Ballroom
4:00 PM - 4:45 PM (EST)
With biotechnology stock index values dipping 20% across the past year and IPO volume down more…
South Broadway Ballroom
6:00 PM - 7:00 PM (EST)
Network and mingle with your fellow attendees at the Welcome Reception on the 9th Floor Upper…
9th Floor Upper Terrace
Tuesday, February 7
9:00 AM - 9:45 AM (EST)
The last five years have been challenging for pain R&D. A new study from BIO found that 77% of…
South Broadway Ballroom
9:00 AM - 11:45 AM (EST)
Company Presentations will take place in the Winter Garden, Palace and Music Box rooms on the 6th…
10:00 AM - 10:45 AM (EST)
With the passage of the U.S. Inflation Reduction Act in August, biopharma companies must consider…
South Broadway Ballroom
11:00 AM - 11:45 AM (EST)
In 2012, the creation of CRISPR-Cas9 revolutionized gene therapy research by providing a multi…
South Broadway Ballroom
12:00 PM - 12:45 PM (EST)
Praveen Tipirneni, MD, MBA is Chief Executive Officer of Morphic Therapeutic Inc. Previously, he…
South Broadway Ballroom
1:00 PM - 1:45 PM (EST)
The most recent FDA reauthorization legislation continues to support thoughtful expansion of real…
South Broadway Ballroom
1:15 PM - 5:00 PM (EST)
Company Presentations will take place in the Winter Garden, Palace and Music Box rooms on the 6th…
2:00 PM - 2:45 PM (EST)
An Alliance Bernstein report cites the potential economic impact of synthetic biology in healthcare…
South Broadway Ballroom
3:00 PM - 3:45 PM (EST)
Supply chain shortages, rising costs, changes in the workforce, and continued macroeconomic…
South Broadway Ballroom
4:00 PM - 4:45 PM (EST)
Despite softening valuations among public biotechs and a major tightening of post-series B private…
South Broadway Ballroom
5:00 PM - 6:00 PM (EST)
Wrap up the in-person portion of the CEO & Investor Conference at the Networking Hour.
6th Floor Pre-Function Area
Company Presentations
Adocia is a clinical-stage biotechnology company that specializes in the development of innovative…
CELLF-BIO is a start-up company formed in North Carolina 2014. The company is currently funded by…
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. is a joint stock company founded in the Zhangjiang…
Medlab is a disruptive, Australian headquartered, Biotechnology company currently listed on the ASX…
SFA Therapeutics is a clinical-stage oral small molecule, novel immunomodulatory focused company…
Tonix is a clinical-stage biopharmaceutical company with a portfolio composed of CNS, rare disease,…
ViCardia Therapeutics, headquartered in San Francisco, is developing GP-531, a novel treatment for…